Table 1 Contraindications for intravitreal anti-VEGF therapies [32, 36, 37].

From: The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice

Contraindications for ALL anti-VEGF therapies

• Hypersensitivity to active substance or any excipients.

• Patients with active or severe intraocular inflammation (IOI) [previous history of anterior uveitis is not considered an exclusion criterion].

• Active or suspected ocular or periocular infections.

Back to article page